EPHA2 and neoplasm: By contrast, EPHA2 harbors some 275 somatic mutations including 164 missense substitutions that have been detected in multiple tumor samples (e.g. stomach, intestine, skin), at relatively low frequencies (typically < 5%) (http://cancer.sanger.ac.uk/cosmic).